These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9410826)

  • 21. PD-L1 Testing in Cancer: Challenges in Companion Diagnostic Development.
    Hansen AR; Siu LL
    JAMA Oncol; 2016 Jan; 2(1):15-6. PubMed ID: 26562503
    [No Abstract]   [Full Text] [Related]  

  • 22. Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer.
    Malik SM; Pazdur R; Abrams JS; Socinski MA; Sause WT; Harpole DH; Welch JJ; Korn EL; Ullmann CD; Hirsch FR
    J Thorac Oncol; 2014 Oct; 9(10):1443-8. PubMed ID: 25521397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings of a Workshop on the Biochemical and Immunologic Diagnosis of Cancer.
    Tumour Biol; 1987; 8(2-3):58-180. PubMed ID: 3448765
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor markers in infancy and childhood.
    Ricafort R
    Pediatr Rev; 2011 Jul; 32(7):306-8. PubMed ID: 21724907
    [No Abstract]   [Full Text] [Related]  

  • 25. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 26. New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival.
    Ambrosone CB; Rebbeck TR; Morgan GJ; Albain KS; Calle EE; Evans WE; Hayes DF; Kushi LH; McLeod HL; Rowland JH; Ulrich CM
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2042-6. PubMed ID: 17119026
    [No Abstract]   [Full Text] [Related]  

  • 27. [Research advances of research on stromal caveolin-1 and tumor energy metabolism].
    Zhao PY; Diao LM; Chen HL
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):498-500. PubMed ID: 22932469
    [No Abstract]   [Full Text] [Related]  

  • 28. Cancer proteomics: developments in technology, clinical use and commercialization.
    Yeat NC; Lin C; Sager M; Lin J
    Expert Rev Proteomics; 2015 Aug; 12(4):391-405. PubMed ID: 26145529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics.
    Clarke W; Chan DW
    Clin Chem Lab Med; 2005; 43(12):1279-80. PubMed ID: 16309362
    [No Abstract]   [Full Text] [Related]  

  • 30. Limitations of biomarkers of exposure in cancer epidemiology.
    Pearce N; de Sanjose S; Boffetta P; Kogevinas M; Saracci R; Savitz D
    Epidemiology; 1995 Mar; 6(2):190-4. PubMed ID: 7742410
    [No Abstract]   [Full Text] [Related]  

  • 31. There and back again: The journey of the estrogen-related receptors in the cancer realm.
    Tam IS; Giguère V
    J Steroid Biochem Mol Biol; 2016 Mar; 157():13-9. PubMed ID: 26151739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomarkers in human developing and pediatric neoplastic tissues.
    Magro G; Musumeci G; Parenti R
    Acta Histochem; 2015; 117(4-5):311-2. PubMed ID: 25891910
    [No Abstract]   [Full Text] [Related]  

  • 33. International Symposium/Workshop on Epidemiology and Prevention of Cancer. Bangkok, Thailand, 2-5 November 1998. Proceedings and abstracts.
    Cancer Lett; 1999 Sep; 143 Suppl 1():S1-52. PubMed ID: 10546589
    [No Abstract]   [Full Text] [Related]  

  • 34. Lack of access to targeted cancer therapy.
    Burki TK
    Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
    [No Abstract]   [Full Text] [Related]  

  • 35. LncRNAs and neoplasia.
    Isin M; Dalay N
    Clin Chim Acta; 2015 Apr; 444():280-8. PubMed ID: 25748036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JAMA Oncology Patient Page. The Evolution of a Cancer.
    West HJ; Jin JO
    JAMA Oncol; 2015 Sep; 1(6):850. PubMed ID: 26247697
    [No Abstract]   [Full Text] [Related]  

  • 37. Biomarkers of Dietary Polyphenols in Cancer Studies: Current Evidence and Beyond.
    Wang J; Tang L; Wang JS
    Oxid Med Cell Longev; 2015; 2015():732302. PubMed ID: 26180594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemistry in tumour diagnosis--who actually needs it?
    Pervez S
    J Pak Med Assoc; 1994 Aug; 44(8):199. PubMed ID: 7996670
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings of the 12th International Workshop on Quantitative Structure-Activity Relationships in Environmental Toxicology, Lyon, France, 8-12 May 2006.
    SAR QSAR Environ Res; 2007; 18(1-2):1-178. PubMed ID: 17365954
    [No Abstract]   [Full Text] [Related]  

  • 40. Emerging molecular markers in oncology: focused therapy, indicators of response, chemoprevention. Proceedings of a workshop. Rovigo, Italy. September 20, 2002.
    Int J Biol Markers; 2003; 18(1):34-86. PubMed ID: 14692414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.